BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3568630)

  • 41. Measuring the 50% haemolytic complement (CH50) activity of serum.
    Costabile M
    J Vis Exp; 2010 Mar; (37):. PubMed ID: 20351687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Binding of erythrocytes of different animal species with human lymphocytes (author's transl)].
    Benesová E; Sálková-Rychtrmocová J; Hermanský F
    Sb Lek; 1977 May; 79(5):135-9. PubMed ID: 405735
    [No Abstract]   [Full Text] [Related]  

  • 43. On the specificity of lectins with a broad agglutination spectrum. V. Further investigations on the tumor-characteristic agglutinin from wheat germ lipase.
    Uhlenbruck G; Gielen W; Pardoe GI
    Z Krebsforsch; 1970; 74(2):171-8. PubMed ID: 4252982
    [No Abstract]   [Full Text] [Related]  

  • 44. [STUDIES ON THE EFFECT OF TANNIN AND FORMALIN ON HETEROANTIGENS OF HUMAN AND ANIMAL ERYTHROCYTES].
    MAJSKY A
    Z Immunitats Allergieforsch; 1964 Apr; 126():312-24. PubMed ID: 14198632
    [No Abstract]   [Full Text] [Related]  

  • 45. A micromodification of the CH50 test for the classical pathway of complement.
    Fetterhoff TJ; McCarthy RC
    J Clin Lab Immunol; 1984 Aug; 14(4):205-8. PubMed ID: 6492124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of complement activity in adult and preterm sheep serum.
    Ahmed S; Kemp MW; Payne MS; Kallapur SG; Stock SJ; Marsh HC; Jobe AH; Newnham JP; Spiller OB
    Am J Reprod Immunol; 2015 Mar; 73(3):232-41. PubMed ID: 25046333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analyzing complement activity in the serum and body homogenates of different fish species, using rabbit and sheep red blood cells.
    Nayak S; Portugal I; Zilberg D
    Vet Immunol Immunopathol; 2018 May; 199():39-42. PubMed ID: 29678228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models.
    Subías M; Tortajada A; Gastoldi S; Galbusera M; López-Perrote A; Lopez Lde J; González-Fernández FA; Villegas-Martínez A; Dominguez M; Llorca O; Noris M; Morgan BP; Rodríguez de Córdoba S
    J Immunol; 2014 Dec; 193(11):5567-75. PubMed ID: 25355917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serological comparison and haemagglutinating activity of Mycoplasma dispar.
    Howard CJ; Gourlay RN; Collins J
    J Hyg (Lond); 1974 Dec; 73(3):457-66. PubMed ID: 4531453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Agglutination of trypsinized sheep erythrocytes by the pili of Corynebacterium renale.
    Honda E; Yanagawa R
    Infect Immun; 1974 Dec; 10(6):1426-32. PubMed ID: 4373397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of carrageenan in complement activation.
    Baker KC; Nicklin S; Miller K
    Food Chem Toxicol; 1986 Sep; 24(9):891-5. PubMed ID: 3096850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The specificity of animal dander allergens: a semi-bland clinical and experimental study.
    Berrens L; Hénocq E; Koers WJ
    Acta Allergol; 1974 Feb; 29(1):10-24. PubMed ID: 4133516
    [No Abstract]   [Full Text] [Related]  

  • 53. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.
    Ling M; Piddlesden SJ; Morgan BP
    Clin Exp Immunol; 1995 Dec; 102(3):582-8. PubMed ID: 8536376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variations in sheep serum conglutinating complement activity and pathway involved in reactivity with sheep erythrocytes sensitized by rabbit antibody.
    Stankiewicz M; Jonas W
    Arch Immunol Ther Exp (Warsz); 1985; 33(3):423-8. PubMed ID: 3851656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of red blood cells strongly coated in vitro by C3 via the alternative pathway.
    Chaplin H; Freedman J; Massey A; Monroe MC
    Transfusion; 1980; 20(3):256-62. PubMed ID: 7385321
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemagglutination test with sheep erythrocytes sensitized with antisera from several mammalian species for the investigation of biological reactivities of staphylococcal protein A.
    Nishihara S; Seki K; Etani S; Masuda S
    Microbiol Immunol; 1986; 30(7):725-30. PubMed ID: 3773793
    [No Abstract]   [Full Text] [Related]  

  • 59. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
    Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Classical pathway evaluation.
    Giclas PC
    Curr Protoc Immunol; 2001 May; Chapter 13():Unit 13.1. PubMed ID: 18432714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.